About
«"Development of therapies targeting the fibroblast growth factor (FGF) pathway for the treatment of fibrosing interstitial lung diseases"»
Thesis Director: Dr. Bernard Mari, Research Director, Institute of Molecular and Cellular Pharmacology (IPMC), CNRS UMR 7275, INSERM UMR 1323, Université Côte d'Azur, IHU RespirERA